Dashboard
Manage Tickers

APGE Apogee Therapeutics, Inc.

Nasdaq apogeetherapeutics.com


$ 56.34 $ 0.14 (0.25 %)    

Monday, 10-Nov-2025 13:07:27 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 621.59 $ 2.80 (0.45 %)
DIA $ 472.44 $ 0.63 (0.13 %)
SPY $ 679.68 $ 2.51 (0.37 %)
TLT $ 89.51 $ 0.02 (0.02 %)
GLD $ 377.44 $ 1.50 (0.4 %)
$ 54.71
$ 56.85
$ 56.30 x 2
$ 56.53 x 102
$ 55.80 - $ 56.85
$ 26.20 - $ 63.50
523,026
na
4.48B
$ 1.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-03-2025 01-01-1970 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-12-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-05-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-28-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

update-apogee-therapeutics-q3-eps-111-beats-120-estimate
Update: Apogee Therapeutics Q3 EPS $(1.11)...
11/10/2025 12:33:33

apogee-therapeutics-q3-2025-net-loss-was-65m-vs-49m-yoy-913m-cash-cash-equivalents-and-marketable-securities-supports-runway-into-2h-2028
Apogee Therapeutics Q3 2025 Net Loss Was $...
11/10/2025 12:18:21

apogee-therapeutics-highlights-apg333-phase-1-results-supporting-combination-development-with-apg777-for-respiratory-diseases
Apogee Therapeutics Highlights APG333 Phas...
11/10/2025 12:13:48

Interim Phase 1 results for APG333 exceeded trial objectives, demonstrated a half-life of approximately 55 days, and suppressed...

craig-hallum-initiates-coverage-on-apogee-therapeutics-with-buy-rating-announces-price-target-of-109
Craig-Hallum Initiates Coverage On Apogee ...
11/03/2025 17:45:02

Craig-Hallum analyst Adam Vogel initiates coverage on Apogee Therapeutics (NASDAQ:APGE) with a Buy rating and announces Pric...

rbc-capital-maintains-outperform-on-apogee-therapeutics-raises-price-target-to-70
RBC Capital Maintains Outperform on Apogee...
11/03/2025 14:37:35

RBC Capital analyst Brian Abrahams maintains Apogee Therapeutics (NASDAQ:APGE) with a Outperform and raises the price target...

mizuho-initiates-coverage-on-apogee-therapeutics-with-outperform-rating-announces-price-target-of-105
Mizuho Initiates Coverage On Apogee Therap...
10/21/2025 12:42:28

Mizuho analyst Joseph Catanzaro initiates coverage on Apogee Therapeutics (NASDAQ:APGE) with a Outperform rating and announc...

btig-reiterates-buy-on-apogee-therapeutics-maintains-115-price-target
BTIG Reiterates Buy on Apogee Therapeutics...
10/09/2025 14:53:14

BTIG analyst Julian Harrison reiterates Apogee Therapeutics (NASDAQ:APGE) with a Buy and maintains $115 price target.

helen-of-troy-ferrari-apogee-therapeutics-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Helen of Troy, Ferrari, Apogee Therapeutic...
10/09/2025 12:29:32

why-richardson-electronics-shares-are-trading-higher-by-over-20-here-are-20-stocks-moving-premarket
Why Richardson Electronics Shares Are Trad...
10/09/2025 09:12:11

reported-earlier-apogee-therapeutics-prices-6951221-common-shares-at-41-each-and-365853-pre-funded-warrants-at-4099-each-in-300m-public-offering
Reported Earlier, Apogee Therapeutics Pric...
10/09/2025 06:14:57

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/08/2025 21:06:05

apogee-therapeutics-launches-an-underwritten-public-offering-of-its-common-stock-no-amount-disclosed
Apogee Therapeutics Launches An Underwritt...
10/08/2025 20:03:48

rbc-capital-initiates-coverage-on-apogee-therapeutics-with-outperform-rating-announces-price-target-of-60
RBC Capital Initiates Coverage On Apogee T...
09/25/2025 13:40:51

RBC Capital analyst Brian Abrahams initiates coverage on Apogee Therapeutics (NASDAQ: APGE) with a Outperform rating and ann...

apogee-therapeutics-says-data-from-phase-2-apex-trial-of-apg777-for-moderate-to-severe-atopic-dermatitis-accepted-for-late-breaker-oral-presentation-at-upcoming-eadv-congress-2025
Apogee Therapeutics Says Data From Phase 2...
09/11/2025 11:31:55

Apogee Therapeutics, Inc., (NASDAQ:APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with pote...

b-of-a-securities-maintains-buy-on-apogee-therapeutics-raises-price-target-to-87
B of A Securities Maintains Buy on Apogee ...
08/28/2025 15:54:20

B of A Securities analyst Tim Anderson maintains Apogee Therapeutics (NASDAQ:APGE) with a Buy and raises the price target fr...

apogee-therapeutics-q2-eps-113-beats-116-estimate
Apogee Therapeutics Q2 EPS $(1.13) Beats $...
08/11/2025 11:35:45

Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(1.13) per share which beat the analyst consensus estimate of $...

gold-falls-1-prokidney-shares-spike-higher
Gold Falls 1%; ProKidney Shares Spike Higher
07/08/2025 17:25:58

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/07/2025 17:06:57

dow-dips-1-mustang-bio-shares-spike-higher
Dow Dips 1%; Mustang Bio Shares Spike Higher
07/07/2025 16:30:43

top-2-health-care-stocks-that-may-plunge-this-month
Top 2 Health Care Stocks That May Plunge T...
07/07/2025 12:26:53

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION